ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
PARADIGM SUBMITS RESPONSES TO US FDA QUESTIONS
Published: 30/06/21, 08:22am (AEST)•2 pages